📊 This is a company profile preview from Tablestat.com Request a Free Trial Now

Company profile: OPKO Health

1.1 - Company Overview

OPKO Health Logo

OPKO Health

Headquarter: United States
Founded: 20XX🔒
Employees: 100-500🔒

Company description

  • Provider of pharmaceuticals and diagnostics based on novel proprietary technologies, including NGENLA, a once-weekly human growth hormone analog for pediatric growth failure due to inadequate endogenous growth hormone secretion, and RAYALDEE, an extended-release oral calcifediol for treating secondary hyperparathyroidism in adults with stage 3 or 4 chronic kidney disease and vitamin D insufficiency.

Products and services

  • Pharmaceutical and diagnostic technology discovery and development: Engages in discovery and development of novel, proprietary technologies for pharmaceuticals and diagnostics
  • NGENLA: A once-weekly human growth hormone analog for pediatric patients with growth failure due to inadequate endogenous growth hormone secretion, engineered for weekly administration in pediatric endocrine care
  • RAYALDEE: An extended-release oral formulation of calcifediol for treating secondary hyperparathyroidism in adults with stage 3 or 4 chronic kidney disease and vitamin D insufficiency, designed for sustained dosing

Key contacts

🔒
🔒

Financial details

🔒

1.2 - Competitors and similar companies to OPKO Health

Centogene Logo

Centogene

HQ: Germany Website
  • Description: Provider of methods and technology for human genetics analysis, delivering genetic diagnostic analyses of rare inherited diseases and transforming global genetic data into medical decisions to create broader awareness for patients of all ethnicities around the world.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Centogene company profile →
Experteam Logo

Experteam

HQ: Italy Website
  • Description: Provider of molecular biology diagnostic systems, researching, developing, and manufacturing these solutions.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Experteam company profile →
Phthisis Diagnostics Logo

Phthisis Diagnostics

HQ: United States Website
  • Description: Provider of molecular diagnostics products for various infectious diseases, leveraging molecular technology to deliver superior quality, ease of use, and cost savings for laboratories.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Phthisis Diagnostics company profile →
Catalog Logo

Catalog

HQ: United States Website
  • Description: Provider of a data conversion and storage platform used to offer next-generation digital data archives.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Catalog company profile →
Devyser Logo

Devyser

HQ: Sweden Website
  • Description: Provider of diagnostic kits for complex DNA testing in oncology, hereditary diseases, and transplantation, used to guide targeted cancer therapies and enable genetic testing. Sold in 60+ countries, offerings include NGS-based tests for thalassemia, cystic fibrosis, familial hypercholesterolemia, thrombophilia, HFE mutations, and Y-chromosome microdeletions linked to male infertility.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Devyser company profile →
🔒

2.M&A buyers

2.1 Potential strategic acquirers in the sector

🔒
🔒
🔒
🔒 View all strategic buyers with complete profiles
Start Free Trial →

2.2 - Strategic buyer groups for OPKO Health

🔒

Buyer group 1: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 2: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 3: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →

3. Investors and private equity firms

3.1 - Buyout funds investing in similar companies to OPKO Health

2.2 - Growth funds investing in similar companies to OPKO Health

🔒 View all growth equity funds with complete profiles
Start Free Trial →

4 - Top valuation comps for OPKO Health

4.2 - Public trading comparable groups for OPKO Health

🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →

4.3 - M&A Transactions similar to OPKO Health

Selected M&A transactions

Date Target Description Buyer(s) Relevance EV EV/Revenue EV/EBITDA
🔒 View all M&A transactions with complete deal terms
Request Free Trial Now →

Frequently Asked Questions

About OPKO Health

What does OPKO Health do?

OPKO Health is a provider of pharmaceuticals and diagnostics based on novel proprietary technologies, including NGENLA, a once-weekly human growth hormone analog for pediatric growth failure due to inadequate endogenous growth hormone secretion, and RAYALDEE, an extended-release oral calcifediol for treating secondary hyperparathyroidism in adults with stage 3 or 4 chronic kidney disease and vitamin D insufficiency.

Who are OPKO Health's competitors?

OPKO Health's competitors and similar companies include Centogene, Experteam, Phthisis Diagnostics, Catalog, and Devyser.

Where is OPKO Health headquartered?

OPKO Health is headquartered in United States.

How many employees does OPKO Health have?

OPKO Health has 1,000 employees 🔒.

When was OPKO Health founded?

OPKO Health was founded in 2010 🔒.

What sector and industry vertical is OPKO Health in?

OPKO Health is in the Enterprise Software 🔒 sector and industry

M&A Buyers & Acquirers for OPKO Health

Who are the top strategic acquirers in OPKO Health's sector and industry

Top strategic M&A buyers and acquirers in OPKO Health's sector include ████████, ██████████, ██████, ████████, and ██████████ 🔒.

Which M&A buyer groups are most relevant for OPKO Health?

Top strategic M&A buyers groups and sectors for OPKO Health include █████████████████ , ████████████████, █████████████, ████████████, and ████████████████ 🔒.

Financial Investors investing in OPKO Health's sector and industry vertical

Which are the top PE firms investing in OPKO Health's sector and industry vertical?

Top PE firms investing in OPKO Health's sector and industry vertical include ████████, ██████████, ████████, and ██████████ 🔒.

Who are the top buyout funds acquiring in OPKO Health's sector and industry vertical?

Active PE funds and buyout funds acquiring companies in OPKO Health's sector and industry vertical include █████████, ██████████, ████████████, and ████████████ 🔒.

Who are the top growth equity funds investing in companies in OPKO Health's sector and industry vertical?

Growth funds and venture capital funds investing in companies similar to OPKO Health include █████████, ██████████, ████████████, and ████████████ 🔒.

Valuation benchmarks of companies in OPKO Health's sector and industry

Which are the key public companies that are relevant trading comps benchmarks for OPKO Health?

The key public trading comparables and valuation benchmarks for OPKO Health include █████████, ██████████, ████████████, and ████████████ 🔒.

Which are the key trading comparable groups for OPKO Health for public valuation benchmarks?

Our platform tracks detailed public trading comparable groups and valuation benchmarks for OPKO Health with complete valuation multiples, growth metrics, and profitability data. Access the full database to benchmark your company against relevant public comparables.

What are recent M&A transactions in OPKO Health's sector and industry vertical?

Our platform tracks relevant M&A transactions comparables and valuation benchmarks for OPKO Health with complete deal terms, valuation multiples, and strategic rationale. Access the full database to benchmark pricing and identify active acquirers.

What are recent capital raises and funding rounds in OPKO Health's' sector and industry vertical?

Access recent funding rounds and capital raises in OPKO Health's sector and industry vertical including growth equity, venture capital, and buyout investments. Our database includes round size, lead investors and valuations.

Ready to Find the Right Buyers?

Access complete buyer lists, valuation data, and M&A intelligence for OPKO Health